Christina DiArcangelo

Founder, CEO Affinity Bio Partners at Corporate Adviser
On the record

An entrepreneur and CEO with more than two decades of experience in the medical cannabis, biotechnology, pharmaceutical, nutraceutical, and medical device industries, Christina’s dedication to revolutionizing patient care is unprecedented. Through her roles as CEO, Spectral Analytics Precision Tele-Monitoring, Founder and CEO of Affinity Bio Partners, Board President and CEO of Affinity Patient Advocacy, and CEO & Co-Founder of AI Health Outcomes, Christina has been involved with revolutionary projects and global clinical studies that positively impact patients.

Recent Quotes
Sign up to view all
  • Given the ever-changing landscape of COVID-19, we are pleased that the FDA recognizes that our original proposed study was a proof-of-concept design under our original Pre-IND submission.

    15 December 2021
Sign up to view all